المؤلفون: Chowdhury, S., Bjartell, A., Agarwal, N., Chung, B. H., Given, R. W., Pereira de Santana Gomes, A. J., Merseburger, A. S., Özgüroğlu, M., Juárez Soto, Soto, Uemura, H., Ye, D., Brookman-May, S. D., Londhe, A., Bhaumik, A., Mundle, S. D., Larsen, J. S., McCarthy, S. A., Chi, K. N.

المصدر: Annals of Oncology eSSENCE: The e-Science Collaboration EpiHealth: Epidemiology for Health. 34(5):477-485

مصطلحات موضوعية: castration resistance, mCSPC, overall survival, PSA progression, radiographic progression-free survival, Medicin och hälsovetenskap, Klinisk medicin, Urologi och njurmedicin, Medical and Health Sciences, Clinical Medicine, Urology and Nephrology

URL الوصول: https://lup.lub.lu.se/record/d137edd3-48d0-4461-bba0-993b79d70dd7
http://dx.doi.org/10.1016/j.annonc.2023.02.009

المؤلفون: Simon Chowdhury, Anders Bjartell, Neeraj Agarwal, Byung H Chung, Andrea J Pereira de Santana Gomes, Axel S Merseburger, Mustafa Özgüroğlu, Álvaro Juárez Soto, Hirotsugu Uemura, Ding-Wei Ye, Sabine D. Brookman-May, Anil Londhe, Kim N. Chi

مصطلحات موضوعية: Oncology and carcinogenesis not elsewhere classified, advanced prostate cancer, apalutamide, castration resistance, deep PSA decline, metastatic castration-sensitive prostate cancer, overall survival, plain language summary, PSA response, radiographic progression-free survival, undetectable PSA

Relation: https://figshare.com/articles/online_resource/Spanish_Translation_-_Prostate-specific_antigen_decline_with_apalutamide_therapy_is_associated_with_longer_survival_and_improved_outcomes_in_individuals_with_metastatic_prostate_cancer_a_plain_language_summary_of_the_TITAN_study/25133441

الاتاحة: https://doi.org/10.25402/fon.25133441.v1
https://figshare.com/articles/online_resource/Spanish_Translation_-_Prostate-specific_antigen_decline_with_apalutamide_therapy_is_associated_with_longer_survival_and_improved_outcomes_in_individuals_with_metastatic_prostate_cancer_a_plain_language_summary_of_the_TITAN_study/25133441

المؤلفون: Murillo-Pineda, Marina, Coto-Cid, Juan M., Romero, María, García Zorrilla, Jesús, Chinchilla Salcedo, Nuria, Medina-Calzada, Zahara, Varela Montoya, Rosa María, Juárez-Soto, Álvaro, Macías Domínguez, Francisco Antonio, Reales Rodríguez, Elena

المساهمون: Biomedicina, Biotecnología y Salud Pública, Química Orgánica

المصدر: Toxins - 2023, Vol. 15 n. 11, artículo número 632

مصطلحات موضوعية: sesquiterpene lactones, grosheimin, costunolide, primary cilia, ciliogenesis

وصف الملف: application/pdf

Relation: info:eu-repo/grantAgreement/Junta de Andalucía//FEDER-UCA18-108266; http://hdl.handle.net/10498/31907

الاتاحة: http://hdl.handle.net/10498/31907
https://doi.org/10.3390/TOXINS15110632

المؤلفون: A. S. Merseburger, N. Agarwal, A. Bhaumik, F. Lefresne, L. I. Karsh, A. J. Pereira de Santana Gomes, Á. Juárez Soto, R. W. Given, S. D. Brookman-May, S. D. Mundle, S. A. McCarthy, H. Uemura, S. Chowdhury, K. N. Chi, A. Bjartell

المساهمون: Исследование проведено при поддержке компании Janssen Research & Development. Представители спонсора (компании Janssen Research & Development) принимали участие в разработке и проведении исследования, сборе, контроле, анализе и интерпретации данных, а также в написании и редактировании текста статьи. Все авторы имели доступ к данным, участвовали в написании статьи при участии спонсора (Janssen), пересмотре и одобрении финальной версии текста статьи, а также приняли решение представить его для публикации. Авторы выражают благодарность пациентам, их родственникам, а также исследователям, координаторам, членам исследовательской группы и медицинскому персоналу. Данная работа была написана при содействии кандидата наук Ларисы Беловой (Parexel) и при финансовой поддержке Janssen Global Services, LLC.

المصدر: Cancer Urology; Том 20, № 1 (2024); 79-93 ; Онкоурология; Том 20, № 1 (2024); 79-93 ; 1996-1812 ; 1726-9776

مصطلحات موضوعية: метастатический кастрационно-чувствительный рак предстательной железы, low-volume, synchronous, metachronous, oligometastatic, polymetastatic, metastatic castration-sensitive prostate cancer, малый объем, синхронный, метахронный, олигометастатический, полиметастатический

وصف الملف: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1809/1528; Francini E., Gray K.P., Xie W. et al. Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC). Prostate 2018;78(12):889–95. DOI:10.1002/pros.23645; Gillessen S., Attard G., Beer T.M. et al. Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019. Eur Urol 2020;77(4):508–47. DOI:10.1016/j.eururo.2020.01.012; Sweeney C.J., Martin A.J., Stockler M.R. et al. Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy. Eur Urol 2021;80(3):275–9. DOI:10.1016/j.eururo.2021.05.016; Fizazi K., Foulon S., Carles J. et al. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. Lancet 2022;399(10336):1695–707. DOI:10.1016/S0140-6736(22)00367-1; Gillessen S., Armstrong A., Attard G. et al. Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol 2022;82(1):115–41. DOI:10.1016/j.eururo.2022.04.002; Bossi A., Foulon S., Maldonado X. et al. Prostate irradiation in men with de novo, low-volume, metastatic, castration-sensitive prostate cancer (mCSPC): results of PEACE-1, a phase 3 randomized trial with a 2 × 2 design. Presented at: 2023 ASCO Annual Meeting, Chicago, IL, USA; 2023.; Armstrong A.J., Szmulewitz R.Z., Petrylak D.P. et al. ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer. J Clin Oncol 2019;37(32):2974–86. DOI:10.1200/JCO.19.00799; Armstrong A.J., Iguchi T., Azad A.A. et al. The efficacy of enzalutamide plus androgen deprivation therapy in oligometastatic hormone-sensitive prostate cancer: a post hoc analysis of ARCHES. Eur Urol 2023;84(2):229–41. DOI:10.1016/j.eururo.2023.04.002; Armstrong A.J., Iguchi T., Azad A. et al. Overall survival (OS) in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) treated with enzalutamide (ENZA) + androgen deprivation therapy (ADT) by high or low disease volume and progression to mHSPC (M0 at diagnosis) or de novo mHSPC (M1 at diagnosis): post hoc analysis of the phase 3 ARCHES trial. J Clin Oncol 2021;40(Suppl.6):115. DOI:10.1200/JCO.2022.40.6_suppl.115; Armstrong A.J., Iguchi T., Azad A. et al. The efficacy of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) on bone oligometastatic hormone-sensitive prostate cancer: a post hoc analysis of ARCHES. J Clin Oncol 2021;39(Suppl.15):5071. DOI:10.1200/JCO.2021.39.15_suppl.5071; Azad A., Villers A., Alekseev B. et al. Efficacy of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) in men with de novo (M1) metastatic hormone-sensitive prostate cancer (mHSPC) versus progression to mHSPC (M0): post hoc analysis of the phase III ARCHES trial. J Clin Oncol 2021;39(Suppl.6):102. DOI:10.1200/JCO.2021.39.6_suppl.102; Armstrong A.J., Azad A.A., Iguchi T. et al. Improved survival with enzalutamide in patients with metastatic hormone-sensitive prostate cancer. J Clin Oncol 2022;40(15):1616–22. DOI:10.1200/JCO.22.00193; Azad A.A., Armstrong A.J., Alcaraz A. et al. Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk. Prostate Cancer Prostatic Dis 2022;25(2):274–82. DOI:10.1038/s41391-021-00436-y; Gravis G., Boher J.M., Chen Y.H. et al. Burden of metastatic castrate naive prostate cancer patients, to identify men more likely to benefit from early docetaxel: further analyses of CHAARTED and GETUG-AFU15 studies. Eur Urol 2018;73(6):847–55. DOI:10.1016/j.eururo.2018.02.001; Gravis G., Boher J.M., Joly F. et al. Androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in metastatic non castrate prostate cancer: impact of metastatic burden and long-term survival analysis of the randomized phase 3 GETUG-AFU15 trial. Eur Urol 2016;70(2):256–62. DOI:10.1016/j.eururo.2015.11.005; Kyriakopoulos C.E., Chen Y.H., Carducci M.A. et al. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase, respectively III E3805 CHAARTED trial. J Clin Oncol 2018;36(11):1080–7. DOI:10.1200/JCO.2017.75.3657; Tripathi A., Chen Y.H., Jarrard D.F. et al. Eight-year survival rates by baseline prognostic groups in patients with metastatic hormone-sensitive prostate cancer (mHSPC): an analysis from the ECOG-ACRIN 3805 (CHAARTED) trial. J Clin Oncol 2022;40(Suppl.16):5081. DOI:10.1200/JCO.2022.40.16_suppl.5081; Vale C.L., Fisher D., Godolphin P. et al. Defining more precisely the effects of docetaxel plus ADT for men with mHSPC: meta-analysis of individual participant data from randomized trials. J Clin Oncol 2022;40(Suppl.16):5070. DOI:10.1200/JCO.2022.40.16_suppl.5070; Vale C.L., Fisher D.J., Godolphin P.J. et al. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. Lancet Oncol 2023;24(7):783–97. DOI:10.1016/S1470-2045(23)00230-9; Hussain M., Tombal B., Saad F. et al. Darolutamide plus androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer by disease volume and risk subgroups in the phase III ARASENS trial. J Clin Oncol 2023:JCO2300041. DOI:10.1200/JCO.23.00041; Sweeney C.J., Martin A.J., Stockler M.R. et al. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial. Lancet Oncol 2023;24(4):323–34. DOI:10.1016/S1470-2045(23)00063-3; Chi K.N., Agarwal N., Bjartell A. et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 2019;381(1):13–24. DOI:10.1056/NEJMoa1903307; Chi K.N., Chowdhury S., Bjartell A. et al. Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study. J Clin Oncol 2021;39(20):2294–303. DOI:10.1200/JCO.20.03488; Bjartell A., Agarwal N., Karsh L. et al. Relationships of sites and burden of metastases with long-term outcomes and molecular subtypes in TITAN. Abstr MP24-08. J Urol 2021;206(Suppl.3):e414–5. DOI:10.1097/JU.0000000000002015.08; Bjartell A., Ye D., Agarwal N. et al. Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: outcomes in patients (pts) with de novo (D1) mCSPC vs. progression to mCSPC after localized disease (D0) at diagnosis. Eur Urol Open Sci 2020;19(Suppl.2):e863. DOI:10.1016/S2666-1683(20)33159-1; Chowdhury S., Bjartell A., Merseburger A.S. et al. Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC): outcomes in high-volume (HV) and low-volume (LV) disease from the titan final analysis (FA). Eur Urol 2021;79(Suppl.1):S1180–1. DOI:10.1016/S0302-2838(21)01220-3; Scher H.I., Halabi S., Tannock I. et al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol 2008;26(7):1148–59. DOI:10.1200/JCO.2007.12.4487; Chi K.N., Saad F., Chowdhury S. et al. Prostate-specific antigen (PSA) kinetics in patients (pts) with advanced prostate cancer treated with apalutamide: results from the TITAN and SPARTAN studies. J Clin Oncol 2020;38(Suppl.15):5541. DOI:10.1200/JCO.2020.38.15_suppl.5541; Chowdhury C., Bjartell A., Agarwal N. et al. Apalutamide for metastatic castration-sensitive prostate cancer in TITAN: prognostic importance of prostate-specific antigen responses. J Urol 2020;203(4S):e250. DOI:10.1097/JU.0000000000000844.011; Chowdhury S., Bjartell A., Agarwal N. et al. Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer. Ann Oncol 2023;34(5):477–85. DOI:10.1016/j.annonc.2023.02.009; Armstrong A.J., Shore N.D., Szmulewitz R.Z. et al. Efficacy of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread: ARCHES post hoc analyses. J Urol 2021;205(5):1361–71. DOI:10.1097/JU.0000000000001568; Davis I.D., Martin A.J., Stockler M.R. et al. Enzalutamide with standard first-line therapy in metastatic prostate cancer. N Engl J Med 2019;381(2):121–31. DOI:10.1056/NEJMoa1903835; National Comprehensive Cancer Network. Prostate cancer. Version 1. 2023-September 16, 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf (accessed 15th November 2022).; Smith M.R., Hussain M., Saad F. et al. Darolutamide and survival in metastatic, hormone-sensitive prostate cancer. N Engl J Med 2022;386(12):1132–42. DOI:10.1056/NEJMoa2119115; Chi K.N., Merseburger A.S., Ozguroglu M. et al. The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN. J Clin Oncol 2022;40(Suppl.6):89. DOI:10.1200/JCO.2022.40.6_suppl.089; https://oncourology.abvpress.ru/oncur/article/view/1809

الاتاحة: https://oncourology.abvpress.ru/oncur/article/view/1809
https://doi.org/10.17650/1726-9776-2024-20-1-79-93

المؤلفون: Agarwal, Neeraj, McQuarrie, Kelly, Bjartell, Anders, Chowdhury, Simon, Pereira de Santana Gomes, Andrea J., Chung, Byung Ha, Özgüroğlu, Mustafa, Juárez Soto, Álvaro, Merseburger, Axel S., Uemura, Hirotsugu, Ye, Dingwei, Given, Robert, Basch, Ethan, Miladinovic, Branko, Lopez-Gitlitz, Angela, Chi, Kim N.

المصدر: The Journal of urology EpiHealth: Epidemiology for Health. 206(4):914-923

مصطلحات موضوعية: apalutamide, neoplasm metastasis, prostatic neoplasms, quality of life, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Urologi och njurmedicin, Urology and Nephrology

URL الوصول: https://lup.lub.lu.se/record/d9b45cb0-ee40-4ad0-a9a7-d7ec23e9fa17
http://dx.doi.org/10.1097/JU.0000000000001841

المؤلفون: Marina Murillo-Pineda, Juan M. Coto-Cid, María Romero, Jesús G. Zorrilla, Nuria Chinchilla, Zahara Medina-Calzada, Rosa M. Varela, Álvaro Juárez-Soto, Francisco A. Macías, Elena Reales

المصدر: Toxins, Vol 15, Iss 11, p 632 (2023)

مصطلحات موضوعية: sesquiterpene lactones, grosheimin, costunolide, primary cilia, ciliogenesis, Medicine

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6651/15/11/632; https://doaj.org/toc/2072-6651

URL الوصول: https://doaj.org/article/2bcc0eb569e447c5b4ab0d9e0fc497db

المؤلفون: Nelson Canales Casco, María Jiménez Carmona, Álvaro Juárez Soto

المصدر: International Brazilian Journal of Urology, Vol 46, Iss suppl 1, Pp 86-92 (2020)

مصطلحات موضوعية: Penile Neoplasms, Clinical Protocols, COVID-19 [Supplementary Concept], Pandemics, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382020000700086&tlng=en; http://www.scielo.br/pdf/ibju/v46s1/1677-6119-ibju-46-s01-0086.pdf; https://doaj.org/toc/1677-6119

URL الوصول: https://doaj.org/article/19614e139304492c9808627eefa55939

المؤلفون: Rodriguez-Vida, Alejo, Rodríguez-Alonso, Andrés, Useros-Rodríguez, Eduardo, Lopez-Campos, Fernando, Amor-Carro, Oscar, Arribas-Ruiz, Alberto, Martínez-Torres, Javier, Roca-Pardiñas, Javier, Quesada-García, Alba, Muñoz-Del-Toro, Jacobo R., Juárez-Soto, Álvaro

مصطلحات موضوعية: Apalutamide, Darolutamide, Enzalutamide, Next-generation anti-androgens, Survival analysis

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10230/53783; http://dx.doi.org/10.1016/j.clgc.2021.11.008

الاتاحة: http://hdl.handle.net/10230/53783
https://doi.org/10.1016/j.clgc.2021.11.008

المؤلفون: A.S. Bjartell, D. Ye, N. Agarwal, B.H. Chung, R. Given, A. Merseburger, M. Özgüroğlu, A. Juárez Soto, H. Uemura, A. Lopez-Gitlitz, G. Li, S. Mc Carthy, K.N. Chi, S. Chowdhury

المصدر: European Urology Open Science, Vol 19, Iss , Pp e863-e864 (2020)

مصطلحات موضوعية: Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666168320331591; https://doaj.org/toc/2666-1683

URL الوصول: https://doaj.org/article/ac49e495abb4422b9063f4f0cdd89d46

المؤلفون: Chi, Kim N, Agarwal, Neeraj, Bjartell, Anders, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Deprince, Kris, Naini, Vahid, Li, Jinhui, Cheng, Shinta, Yu, Margaret K, Zhang, Ke, Larsen, Julie S, McCarthy, Sharon, Chowdhury Simon, TITAN Investigators, Sciarra Alessandro

المساهمون: Chi, Kim N, Agarwal, Neeraj, Bjartell, Ander, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Deprince, Kri, Naini, Vahid, Li, Jinhui, Cheng, Shinta, Yu, Margaret K, Zhang, Ke, Larsen, Julie S, Mccarthy, Sharon, Chowdhury, Simon, Titan, Investigator, Sciarra, Alessandro

مصطلحات موضوعية: prostate cancer, apalutamide, hormone therapy

Relation: info:eu-repo/semantics/altIdentifier/pmid/31150574; info:eu-repo/semantics/altIdentifier/wos/WOS:000474094900008; volume:381; issue:1; firstpage:13; lastpage:24; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11573/1294771; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068436470

الاتاحة: http://hdl.handle.net/11573/1294771
https://doi.org/10.1056/NEJMoa1903307

المؤلفون: Á, Juárez-Soto, N, Canales-Casco, V, Quintero-Gómez, E, Ruiz-Rosety, M, de Paz-Suárez, R, Campanario-Pérez

المصدر: Actas Urológicas Españolas (English Edition). 46:456-463

مصطلحات موضوعية: Male, Treatment Outcome, Humans, Inguinal Canal, Lymph Node Excision, Endoscopy, Female, General Medicine, Middle Aged, Penile Neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cecdd5570c3d689040779b824110e542
https://doi.org/10.1016/j.acuroe.2022.06.006

المؤلفون: Á. Juárez-Soto, N. Canales-Cascos, V. Quintero-Gómez, E. Ruiz-Rosety, M. de Paz-Suárez, R. Campanario-Pérez

المصدر: Actas Urológicas Españolas. 46:456-463

مصطلحات موضوعية: Urology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4d9a6cec5c217168f593626447a9687f
https://doi.org/10.1016/j.acuro.2021.11.009

المؤلفون: R. Campanario, F.J.J. Moscoso, R.G. Martinez, J.A.A. Muñoz, M.H. Torres, M. Sanchez, A. Juarez Soto

المصدر: European Urology Open Science, Vol 19, Iss , Pp e1850-e1851 (2020)

مصطلحات موضوعية: Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Relation: http://www.sciencedirect.com/science/article/pii/S2666168320338477; https://doaj.org/toc/2666-1683; https://doaj.org/article/5236eaeb5de549689695456d44acf01f

الاتاحة: https://doi.org/10.1016/S2666-1683(20)33847-7
https://doaj.org/article/5236eaeb5de549689695456d44acf01f

المؤلفون: Chowdhury*, Simon, Bjartell, Anders, Agarwal, Neeraj, Chung, Byung Ha, Given, Robert W., Pereira de Santana Gomes, Andrea J., Merseburger, Axel S., Özgüroğlu, Mustafa, Juárez Soto, Alvaro, Uemura, Hirotsugu, Ye, Dingwei, Lopez-Gitlitz, Angela, Londhe, Anil, Mundle, Suneel, Larsen, Julie S., McCarthy, Sharon, Chi, Kim N.

المصدر: Journal of Urology ; volume 203, issue Supplement 4 ; ISSN 0022-5347 1527-3792

الاتاحة: http://dx.doi.org/10.1097/ju.0000000000000844.011
http://journals.lww.com/10.1097/JU.0000000000000844.011

المؤلفون: Bjartell, A.S., Ye, D., Agarwal, N., Chung, B.H., Given, R., Merseburger, A., Özgüroğlu, M., Juárez Soto, A., Uemura, H., Lopez-Gitlitz, A., Li, G., Mc Carthy, S., Chi, K.N., Chowdhury, S.

المصدر: European Urology Open Science ; volume 19, page e863-e864 ; ISSN 2666-1683

الاتاحة: http://dx.doi.org/10.1016/s2666-1683(20)33159-1
https://api.elsevier.com/content/article/PII:S2666168320331591?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666168320331591?httpAccept=text/plain

المؤلفون: Campanario, R., Moscoso, F.J.J., Martinez, R.G., Muñoz, J.A.A., Torres, M.H., Sanchez, M., Juarez Soto, A.

المصدر: European Urology Open Science ; volume 19, page e1850-e1851 ; ISSN 2666-1683

الاتاحة: http://dx.doi.org/10.1016/s2666-1683(20)33847-7
https://api.elsevier.com/content/article/PII:S2666168320338477?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2666168320338477?httpAccept=text/plain

المؤلفون: María Marqueta de Salas, Lorena Rodríguez Gómez, Diego Enjuto Martínez, José Juan Juárez Soto, José Javier Martín-Ramiro

المصدر: Revista Española de Salud Pública, Vol 91, Pp 1-10 (2017)

مصطلحات موضوعية: Medicine, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: http://www.redalyc.org/articulo.oa?id=17049838023; https://doaj.org/toc/1135-5727; https://doaj.org/toc/2173-9110

URL الوصول: https://doaj.org/article/54372beeb1294f54bf4a5e9be8a35a76

المؤلفون: Pedraza Sánchez, José Pablo, Chaves-Marcos, Reyes, Mazuecos Quirós, Javier, Bisonó-Castillo, Álvaro Luis, Osman-García, Ignacio, Gutiérrez-Marín, Carlos Miguel, Medina López, Rafael Antonio, Juárez-Soto, A.

مصطلحات الفهرس: Radiofrequency ablation, Nephrectomy, Interventional radiology, Minimally invasive surgery, Renal cancer, artículo

URL: http://hdl.handle.net/10261/352232
https://doi.org/10.1007/s00330-023-09779-7
The underlying dataset has been published as supplementary material of the article in the publisher platform at http://dx.doi.org/10.1007/s00330-023-09779-7
https://doi.org/10.1007/s00330-023-09779-7
Sí

المؤلفون: Chung, B.H., McQuarrie, K., Bjartell, A., Chowdhury, S., Pereira de Santana Gomes, A.J., Özgüroğlu, M., Juárez Soto, Á., Merseburger, A.S., Uemura, H., Ye, D., Given, R., Miladinovic, B., Li, N., Hudgens, S., Floden, L., Lopez-Gitlitz, A., Chi, K.N., Agarwal, N.

المصدر: Annals of Oncology ; volume 30, page ix68 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1093/annonc/mdz424
https://api.elsevier.com/content/article/PII:S0923753419578851?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753419578851?httpAccept=text/plain
http://academic.oup.com/annonc/article-pdf/30/Supplement_9/mdz424/31094114/mdz424.pdf

المؤلفون: Murillo-Pineda, Marina, Coto-Cid, Juan M., Romero, María, Zorrilla, Jesús G., Chinchilla, Nuria, Medina-Calzada, Zahara, Varela, Rosa M., Juárez-Soto, Álvaro, Macías, Francisco A., Reales, Elena

المصدر: Toxins; Nov2023, Vol. 15 Issue 11, p632, 15p

مصطلحات موضوعية: CILIA & ciliary motion, SESQUITERPENE lactones, CONFOCAL fluorescence microscopy, RHODOPSIN, CELL cycle